Study of the thermal stability and enzymatic activity of an immobilised enzymatic system for the bilirubin oxidation by Vidal, M. M. et al.
Biomaterials 20 (1999) 757—763
Study of the thermal stability and enzymatic activity of an immobilised
enzymatic system for the bilirubin oxidation
M.M. Vidal!, M.H. Gil!,*, I. Delgadillo", J. Alonso#
!Departamento de Engenharia Quimica, Universidade de Coimbra, Faculdade de Ciencias e Technologia, 3000 Coimbra, Portugal
"Departamento Quı«mica, Universidade de Aveiro, 3830 Aveiro, Portugal
#Grupo de Sensores y Biosensores, Departamento de Quı«mica, UAB, 08193 Bellaterra, Spain
Received 26 February 1998; accepted 10 November 1998
Abstract
In this work, we have studied the immobilisation of the haemoglobin/glucose oxidase coupled enzymatic system in poly(vinyl
alcohol) membranes. These are to be used as a reagent phase either in the development of an optical sensor or as an eƒcient bilirubin
(BR) removal reactor. Poly(vinyl alcohol) (PVA) was chosen as the support for this purpose, due to its good biocompatibility,
hydrophilicity and non-thrombogenic e⁄ects. A hydrogel containing the enzymatic system, consisting of PVA crosslinked with
glutaraldehyde, was prepared and characterised by DSC, enzyme activity measurements and release tests. Investigating protein
conformational changes as a function of temperature and the enzymatic system activity we have found that, in spite of the
destabilizing e⁄ect of the glutaraldehyde in the acidic medium, the PVA insolubilisation conditions seem do not perturb either the
conformation of the Ônative stateÕ nor the enzymatic system activity. Moreover, it was found that PVA/glutaraldehyde membranes
o⁄er a simple way to hold enzymatic system, with the possibility of controlling the conditions to obtain either the e⁄ective prevention
of leaching of the entrapped proteins or the in situ delivery of the haemoglobin. ( 1999 Elsevier Science Ltd. All rights reserved
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1. Introduction
Bilirubin is a metabolite of blood haem breakdown
and is potentially toxic to plasma membranes. High
levels of BR is of much concern in new-born babies
(physiologic jaundice) while in adults, quantitative detec-
tion of abnormal levels provides accurate information
about troubles in BR metabolism. Bilirubin (BR) can be
determined in several ways, although the most common
method still involves the van den Bergh reaction, em-
ploying diazotized sulphanilic acid to form red azodipyr-
roles [1, 2].
Many e⁄orts have been made to obtain more accurate
and simple routine analytical methods [3—9]. Special
attention has been given to the application of the en-
zymes. In the literature di⁄erent enzymatic systems have
been suggested: glucose oxidase and peroxidase [10, 11],
bilirubin oxidase alone [8, 9, 12—15] or together with
peroxidase and glucose oxidase [16, 17], to enhance BR
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degradation e⁄ect. Some of these enzymatic methods are
also suitable for BR removal from blood where the en-
zyme speciÞcity is very important, due to the necessity to
avoid the elimination of other essential blood compo-
nents, thus minimizing the volume of the blood in the
extracorporeal circuit [12, 16].
In a previous work, we have proposed an inexpensive
and accessible coupled enzymatic system for BR oxida-
tion [18]. This involves haemoglobin (Hb) and glucose
oxidase (GOX): Hb and hydrogen peroxide oxidise BR to
a colourless compound, with the hydrogen peroxide be-
ing produced in situ by the well-established glucose
oxidase catalysed reaction.
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The work presented here reports the development of
a PVA membrane containing the Hb/GOX enzymatic
system, which works as the biochemical recognition
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Fig. 1. Schematic representation of the experimental procedure for the
activity assay of the immobilised Hb/GOX system.
system. The membrane was obtained by crosslinking
PVA and the enzymatic system with glutaraldehyde con-
sisting in a quite advantageous procedure due to its
simplicity and ability to hold high matrix loads. In this
stage of our work, well characterised membranes of small
dimensions were prepared and tested. The e⁄ect of the
crosslinking conditions on the protein structure and on
the enzyme activity were evaluated by DSC. In this way,
we investigated the protein conformational changes as
a function of temperature in the presence of the glutaral-
dehyde. The aim of our investigations consisted in
following any proÞle changes on the proteins thermal
denaturation considering the native enzyme proÞle as
a reference. In the end, we tried to relate the observed
conformational changes with the enzyme activity.
2. Experimental part
2.1. Reagents
Poly(vinyl alcohol) (molecular weight of 14 000, 98%
hydrolysed) was obtained from BDH, Chemicals Ltd,
Poole, England. Bovine haemoglobin (Hb), glucose
oxidase (GOX EC 1.1.3.4) from Aspergillus niger type
VII, bovine serum albumin (BSA) and bilirubin (BR)
from bovine gall stones were obtained from Sigma
Chemical Co., sodium dodecyl sulphate (SDS) and
tris(hydroxylmethyl)aminomethane were purchased
from Aldrich Chemical Company Inc. (England) and
HCl (37%) and glutaraldehyde (25%) from Merck
(Darmstadt, Germany).
2.2. Preparation of the membranes
Membranes were prepared: with PVA (procedure A)
and without PVA (procedure B). The solutions obtained
were cast on a glass plate (2 cm]2 cm) and the solvent
evaporated for 24 h at 25¡C. PVA solution was prepared
by dissolving PVA (10% w/w) in water at 80¡C until
complete solubilization. Glutaraldehyde standard solu-
tion was prepared by diluting to 50 cm3, with distilled
water, 3 cm3 of commercial glutaraldehyde solution
(25%).
2.2.1. Procedure A—PVA membranes
To 4 cm3 of the aqueous PVA solution (10% w/w),
0.3 cm3 of 0.5 M HCl and 2.5 cm3 of the glutaraldehyde
standard solution were added. Then, 0.68 cm3 of this
PVA solution were added to the proteins (Hb or Hb and
GOX), previously solubilised in 0.32 cm3 of distilled
water.
2.2.2. Procedure B—protein/glutaraldehyde mixtures
0.3 cm3 of water and 2.5 cm3 of the glutaraldehyde
standard solution were added to 4 cm3 of distilled
water. 0.68 cm3 of this aqueous glutaraldehyde solution
was added to solution of the proteins (Hb or Hb and
GOX) in distilled water (0.32 cm3). A similar procedure
was followed to study the inßuence of the acid medium
adding 0.3 cm3 of 0.5 M HCl instead of the 0.3 cm3 of
water.
2.3. Enzymatic assay
Figure 1 shows, schematically, the experimental pro-
cedure, used to assay the enzymatic activity of the PVA
membranes (procedure A). For the enzymatic assay, 100
and 20 lM BR/albumin standard solutions were pre-
pared as previously described [18]. A 0.1 M Tris bu⁄er
solution (pH"8) was prepared containing SDS (de-
noted Tris/SDS). According to the optimum level estab-
lished by Bergmeyer, 5 mM SDS concentration was
chosen to cleave BR/albumin association and assure
a quick oxidation of the BR [1, 18]. 0.05 M glucose and
0.1 mg/cm3 GOX solutions were prepared with this
Tris/SDS bu⁄er. For the activity determination of the
membranes containing Hb and GOX, BR solutions
were prepared by mixing 1 cm3 of the 100 lM BR/
albumin standard solution with 1.5 cm3 of the Tris/SDS
bu⁄er and 0.5 cm3 of the glucose solution. For the
activity determination of membranes containing only
Hb, the BR solutions contained not only 1 cm3 of
a 20 lM BR standard solution and 1 cm3 of Tris/SDS
bu⁄er, but also 0.5 cm3 of glucose 0.05 M and 0.5 cm3 of
GOX 0.1 mg/cm3. The absorbance values at 450 nm, of
these BR sample solutions, were determined. Then the
membranes were introduced in the vessels containing
the BR solutions. The BR oxidation was then carried
out for 15 min with stirring. The reaction was stopped
with the membrane remotion. Absorbance values at
450 nm of the BR sample solution was determined once
again. Both absorbance values at 450 nm, before and
after contact with the membrane were compared (spec-
trum a and b, respectively).
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Fig. 2. A, Thermogram of haemoglobin-powdered sample (4.2 mg); thermograms of the Hb/glutaraldehyde mixtures, in accordance with procedure B.
B, without HCl (2.4 mg); C, with HCl (2.0 mg).
2.4. DSC measurements
Di⁄erential scanning calorimetry (DSC) thermograms
were obtained using a Polymer Laboratories DSC unit.
The samples, consisting of the proteins/glutaraldehyde
mixtures (procedure B) were dried to constant weight in
vacuum in the presence of P
2
O
5
at 25¡C. 2—5 mg samples
of these membranes were analysed at a 10¡C/min heating
rate, under a nitrogen atmosphere.
3. Results and discussion
The enzymatic system was immobilised by occlusion in
a PVA gel made by adding glutaraldehyde to a PVA
solution. The reaction between hydroxyl and aldehyde
groups is acid catalysed, leading to an acetal linkage [18,
19]. The inßuence of pH and glutaraldehyde on the
thermal stability of the proteins (Hb and GOX separate-
ly) was determined.
3.1. Haemoglobin thermal stability
Figure 2 shows the DSC thermograms for Hb thermal
denaturation. Curve A corresponds to the powdered
sample, where the symbols „
.
and „
$
denote the melting
and the decomposition temperature of the native protein.
The melting or the denaturation of the protein process
leads to an increase of the heat capacity. The maximum
limit is reached, in this case, at about 120¡C, while chem-
ical decomposition occurs around 210¡C, with some loss
of heat capacity.
In the same Þgure, thermograms B and C show the
inßuence of glutaraldehyde in the presence and in the
absence of the acid on the melting and decomposition
processes. The Hb/glutaraldehyde ratio is similar to
those at PVA membranes.
Comparing „
.
values in the thermograms B and
C with the „
.
value in the thermogram A, we can see that
the presence of the glutaraldehyde a⁄ects the „
.
only
when the crosslinking reaction occurs in the acidic me-
dium. In curve C, the slight decrease of the „
.
value,
suggests that, under these conditions, the thermal stabil-
ity of the protein decreases [20]. However, the three Hb
denaturation processes are quite similar and the value of
the width at half-peak height, *„
1@2
, remains constant
and equal to the value obtained for the native protein.
This means that the reaction conditions, for the PVA
insolubilization, does not signiÞcantly perturb the con-
formation of the ÔnativeÕ state [21].
The only thermodynamic parameter which seems to be
a⁄ected signiÞcantly by crosslinking, is the thermal de-
composition of the protein, which disappears in both
Hb/glutaraldehyde mixtures (Fig. 2). This stabilisation of
the protein molecules to thermal decomposition can be
assigned to the well-known phenomenon described in
1948 by Ferry due to the heat-induced association of the
denaturated molecules which, based on the DSC data is
promoted by the addition of the glutaraldehyde [22].
3.2. Glucose oxidase thermal stability
The e⁄ect of the glutaraldehyde on the GOX confor-
mational change, as a function of temperature, was also
investigated. Figures 3 and 4 show the relevant thermo-
grams. In both Þgures, curve A represents the thermo-
gram of the GOX powdered sample, where the three
transitions are identiÞed according to Kennamer [20]: at
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Fig. 3. Thermograms of di⁄erent GOX samples: A, GOX powdered
sample (2 mg); B, GOX/glutaraldehyde mixture (2.1 mg).
Fig. 4. Thermograms of di⁄erent GOX samples: A, GOX powdered sample (2 mg); B, GOX/glutaraldehyde mixture adding HCl (2.2 mg).
54¡C, the glass transition „
’
, followed by the Þrst-order
transition, corresponding to the denaturation process,
and the last transition, at 205¡C, corresponding to pro-
tein decomposition.
Curves B, in both Þgures, show the thermograms of
a GOX/glutaraldehyde mixture, obtained by mixing the
enzyme and the glutaraldehyde at the same ratio as in
a normal PVA membrane (see Experimental Part—pro-
cedure B). In Fig. 3, curve B is related to the GOX/
glutaraldehyde sample prepared without HCl, while in
Fig. 4, curve B is related to the GOX/glutaraldehyde
sample prepared in the acidic medium. In both thermo-
grams B, the disappearance of the peak around 200¡C,
suggests that there is a stabilisation of the GOX, and no
thermal degradation occurs. Probably, as suggested by
Ferry [22], the presence of the glutaraldehyde provides
a way of gelliÞcation of the proteins to stabilise them for
higher temperatures. In Fig. 3, curve B, the glass
transition disappears. It is also evident that there is an
alteration on the enthalpy change of the denaturation
process. Considering the increase in the *„
1@2
value, it is
suggested that, in the presence of glutaraldehyde, the
cooperative degree of the GOX denaturation process
decreases, in agreement with a lower conformational
thermostability.
On the other hand, in the acidic medium (curve B,
Fig. 4) the glass transition, of the GOX/glutaraldehyde
mixture, does not disappear, while decreases both in
„
’
and „
.
values are observed. Therefore, at lower pH
values, although the enzyme becomes thermally unstable
at a lower temperature, according to thermodynamic
parameters such as enthalpy change and the *„
1@2
value,
the GOX is more thermostable. The enthalpy change and
the same degree of cooperativity as the native enzyme
suggest that, in the presence of the glutaraldehyde and for
low pH values, GOX assumes a conformation, identical
to that of the pure enzyme.
3.3. Catalytic activity measurements
In the previous sections, we have shown how glutaral-
dehyde alone or in the presence of HCl can inßuence
thermal stability and conformation of the proteins. Al-
though the glutaraldehyde/acid medium does not seem
to interfere with the protein conformation, here, we re-
port the studies to investigate if there is any undesirable
e⁄ects on Hb and GOX functional properties, after they
were entrapped in the PVA membrane crosslinked with
glutaraldehyde. The catalytic activity of four enzymatic
systems (membranes 1—4), whose composition is de-
scribed in Table 1, were tested by evaluating their capa-
city to oxidise BR to biliverdin.
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Table 1
Composition of the 1—4 PVA membranes prepared with di⁄erent Hb
and GOX concentrations. PVA 4%, HCl 0.015 M and glutaraldehyde
0.4% (w/v)
Material Hb (%) GOX (%) GOX (%) in the
reaction medium
1 2.5 2.5 —
2 0.5 0.5 —
3 5.0 — 1.7
4 0.5 — 1.7
Fig. 5. Oxidation of a 30 lM BR solution, for a 15 min contact, with the
enzymatic system immobilised in a poly(vinyl alcohol) membrane
(a) membrane 1, Hb 2.5 and GOX 2.5%; (b) membrane 2, Hb 0.5%
and GOX 0.5% (the assay procedures are indicated in Fig. 1).
Comparing the results in the Fig. 5a and b, the de-
crease of the absorbance at 450 nm (the rate of the oxida-
tion) is di⁄erent for the membranes 1 and 2. From a brief
study of reproducibility for the membrane 1 (membrane
prepared with the highest enzymatic system concentra-
tion), a standard deviation corresponding to a 25% vari-
ation from the respective mean has been obtained. This
lack of reproducibility could be associated with the Hb
release. Due to these results the system PVA/Hb was
characterised by evaluating the Hb release behaviour.
3.4. Release tests
In order to optimise the system, by decreasing the Hb
releasing, new membranes without GOX were prepared
(membranes 3 and 4). Their behaviour in contact with
a solution containing GOX and BR was studied using the
same batch method (see Fig. 1).
In Fig. 6, spectrum b is related to a 7 lM BR sample
solution after the contact with the membrane 3, contain-
ing a Hb amount corresponding to the sum of Hb and
GOX amount contained in membrane 1 (5.0%). This
spectrum shows a peak at 420 nm, within the Soret re-
gion (400—440 nm). In the same Þgure, for the same
15 min contact time, spectrum c corresponds to a sample,
where the 20 lM BR standard was replaced by an equal
volume of Tris bu⁄er. The absorbance peak at 420 nm is
still observed, and can be assigned to haemoglobin re-
leased into the solution which conÞrm that in these
conditions Hb is leaked. The large overlap between Hb
and BR absorption bands, introduces a systematic error
for quantitative determination of BR (*
1
instead of
*
1
#*
2
). Therefore, a modiÞed spectrophotometric pro-
cedure for BR determination should involve subtraction
of the Hb absorbance (*
2
), from spectrum b. This opera-
tion leads to a new spectrum (d—dashed line) which
allows the estimation of the real BR enzymatic degrada-
tion (*
1
#*
2
).
With membrane 4, prepared with less Hb amount
(0.5%), in a similar way, spectra a—d are represented in
Fig. 7. Spectra b and c, for the samples, with and without
BR after contact with the membrane, do not show the
characteristic Hb band. The BR absorption band does
not overlap and the decrease of the absorbance, at
450 nm, between spectrum c and b is close to that due to
the BR oxidation (*
1
#*
2
+*
1
). This means that, we
have found a way to prevent Hb leakage when using the
PVA/glutaraldehyde membrane to immobilise the pro-
teins. This consisted in reducing the initial Hb amount
entrapped within the hydrogel.
In addition, from the results obtained (see absorbance
di⁄erence at 450 nm between spectra a and d in Figs. 6
and 7), we also can conclude that the absorbance de-
crease is similar for both membranes 3 and 4. These PVA
membranes can therefore be designed to degrade BR,
either by releasing Hb (for solutions containing GOX) or
by not releasing the Hb. If the Hb is not released, BR
is degraded after its ingress, and H
2
O
2
obtained from
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Fig. 6. Spectrophotometric absorption curves for membrane 3: a, 7 lM
BR sample; b, the same 7 lM BR sample, for a 15 min contact; c, sample
solution with no BR, for a 15 min contact; d, spectrum b with Hb
absorbance subtracted.
Fig. 7. Spectrophotometric absorption curves for membrane 4: a, 7 lM
BR sample; b, the same 7 lM BR sample, for a 15 min contact; c, sample
solution with no BR, for a 15 min contact; d, spectrum b with Hb
absorbance subtracted.
solution, in the membrane (membrane 4). If Hb is re-
leased both phenomena can occur, i.e. BR is degraded
inside and outside of the membrane. In both cases, the
percentage of degradation is the same, which, however,
could be due to the substrate concentration becoming the
limiting factor. In fact when BR concentration is in-
creased as it was for the enzymatic assay of membranes
1 and 2, membrane 1, containing higher amount of the
enzymatic system, appears to be much more eƒcient
than membrane 2. However, in this case, GOX could
become the limiting factor of the system.
The achievements reported in the previous discussion
are of especial importance if we consider to what these
membranes are made for. Depending on the Hb amount
used on the membrane preparation, it is possible to
prepare, on the one hand, polymeric systems providing
the e⁄ective prevention of leaching of the entrapped
proteins, which is very convenient to avoid the blood
contamination when used as a reactor for the detoxiÞca-
tion of BR. On the other hand, it allows to prepare
polymeric systems for the in situ delivery of the haemo-
globin as self-contained biosensors for in vivo monitor-
ing of BR concentration in mediums, such as the gastric
juice, where the continuous Hb supply is an essential
demanding factor [23, 24].
4. Conclusions
The Hb/GOX coupled system was immobilised by
occlusion in a PVA gel, which will be used as a reagent
phase in the development of an optical sensor or an
eƒcient BR removal reactor. We have used DSC for
investigating protein conformational changes as a func-
tion of temperature, under the PVA gelling reaction
conditions and simultaneously, catalytic activity
measurements and release tests were performed.
From our results we can conclude that:
1. Both Hb/glutaraldehyde/acid and GOX/glutaral-
dehyde/acid become thermally instable at lower tem-
peratures, though conformational changes of both
proteins are identical to those of the native state.
2. We were successful in maintaining the catalytic activ-
ity of the enzymatic system within the PVA hydrogel,
though there is also the possibility of using these
hydrogels to release Hb.
Based on this work, we can conclude that the develop-
ment of membranes with controlled permeability is fun-
damental for further development of a biosensor. As
referred to earlier [17] the main factors that inßuence the
permeability properties are the enzymatic system/poly-
mer ratio (loading) and the crosslinking density.
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